Management of HIV-1 Infection in Children

作者: Michael T. Brady

DOI: 10.2165/00115677-199804020-00002

关键词:

摘要: Optimal management of human immunodeficiency virus type 1 (HIV-1)-infected children requires a commitment from the healthcare delivery system, providers, and affected families caregivers. When adequate resources are available (as in most industrialised nations), an aggressive approach to early identification at-risk populations, diagnosis, therapy is associated with marked health benefits cost efficiency. Much morbidity high costs HIV-1 care related HIV-1—related complications. Some, but not all, these could be prevented or lessened by earlier infection use antiretroviral for prophylaxis against opportunistic infections. Prevention any always preferable treatment. The greatest optimism those caring HIV-1—infected has been provided success preventing mother-to-infant transmission. A goal reducing perinatal transmission nations 25% 2% less very reasonable. recent Thailand provides hope that privileged areas world burdens might also capable benefiting intervention strategies will accessible them.

参考文章(57)
William W. Freimuth, Delavirdine Mesylate, a Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitor Advances in Experimental Medicine and Biology. ,vol. 394, pp. 279- 289 ,(1996) , 10.1007/978-1-4757-9209-6_25
Pardi G, Newell Ml, Dunn Dt, Semprini Ae, Peckham Cs, Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study. AIDS. ,vol. 10, pp. 1675- 1681 ,(1996)
James J. Goedert, Anne Willoughby, Robert P. Nugent, David N. Burns, Larry R. Muenz, Judith H. Walsh, Sheldon Landesman, Arye Rubinstein, Hermann Mendez, Howard Minkoff, Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels. Journal of Acquired Immune Deficiency Syndromes. ,vol. 7, pp. 718- 726 ,(1994)
Pardi G, Newell Ml, Dunn D, Ades Ae, Semprini Ae, Peckham Cs, Risk factors for mother-to-child transmission of HIV-1. European Collaborative Study. The Lancet. ,vol. 339, ,(1992)
Mark W Kline, Lisa M Dunkle, Joseph A Church, Jonathan C Goldsmith, Alice T Harris, Marianne E Federici, Mary E Schultze, Lin Woods, Diane F Loewen, Sanjeev Kaul, Anne Cross, Victoria L Rutkiewicz, Howard M Rosenblatt, I Celine Hanson, William T Shearer, A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection. Pediatrics. ,vol. 96, pp. 247- 252 ,(1995)
P Jarosinski, R N Husson, P Brouwers, P A Pizzo, D Venzon, B U Mueller, L L Lewis, V L Stocker, F M Balis, K M Butler, Clinical and pharmacokinetic evaluation of long-term therapy with didanosine in children with HIV infection. Pediatrics. ,vol. 94, pp. 724- 731 ,(1994)
William T. Shearer, Mark W. Kline, Lisa M. Dunkle, Kim D. Evans, Alice T. Harris, Marianne E. Federici, Courtney V. Fletcher, Victoria L. Rutkiewicz, Combination Therapy With Stavudine and Didanosine in Children With Advanced Human Immunodeficiency Virus Infection: Pharmacokinetic Properties, Safety, and Immunologic and Virologic Effects Pediatrics. ,vol. 97, pp. 886- 890 ,(1996)
Husson Rn, Pizzo Pa, Venzon D, Mueller Bu, Lewis Ll, Jacobsen F, Henry N, Balis Fm, Butler Km, Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine. Pediatrics. ,vol. 91, pp. 747- 751 ,(1993)
Louise Kuhn, Raziya Bobat, Anna Coutsoudis, Daya Moodley, Hoosen M. Coovadia, Wei-Yann Tsai, Zena A. Stein, Cesarean deliveries and maternal-infant HIV transmission: results from a prospective study in South Africa Journal of Acquired Immune Deficiency Syndromes. ,vol. 11, pp. 478- 483 ,(1996) , 10.1097/00042560-199604150-00008